Alimera Sciences Inc
Save
–
Market cap
–
Current P/E
41.84x
Forward P/E
About
Health care
Sector
Drug Manufacturers - Specialty & Generic
Industry
Alimera Sciences, Inc., a pharmaceutical company, engages in the development and commercialization of ophthalmic pharmaceuticals. It operates through United States, internationally, and Operating Cost segments. It offers ILUVIEN, an intravitreal implant for the treatment of diabetic macular edema (DME), which is a disease of the retina that affects individuals with diabetes and lead to severe vision loss and blindness; and to prevent relapse in recurrent non-infectious uveitis affecting the posterior segment of the eye.
Similar securities
Based on sector and market capitalization
Report issue